Page last updated: 2024-12-05

vanadium pentoxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Vanadium pentoxide (V2O5) is a bright orange-red solid that is an important industrial chemical. It is used as a catalyst in the production of sulfuric acid, as a pigment in ceramics and glass, and as a component of batteries. Vanadium pentoxide is typically synthesized by the oxidation of vanadium metal, vanadium dioxide, or vanadium trioxide. The compound is typically prepared by reacting vanadium metal with oxygen at high temperatures. Vanadium pentoxide has a wide range of applications, including in catalysis, pigments, and batteries. It is an effective catalyst for a variety of reactions, including the oxidation of sulfur dioxide to sulfur trioxide in the production of sulfuric acid. Vanadium pentoxide is also used as a pigment in ceramics and glass, where it imparts a yellow or orange color. In addition, it is a component of some batteries, where it acts as an electrode material. Vanadium pentoxide is studied for its potential applications in a variety of fields, including catalysis, energy storage, and environmental remediation. Its catalytic properties make it suitable for a variety of industrial processes. Its ability to store energy makes it a promising candidate for use in batteries and fuel cells. And its ability to remove pollutants from the environment makes it a valuable tool for environmental remediation.'

Cross-References

ID SourceID
PubMed CID14814
CHEBI ID30045
MeSH IDM0181454

Synonyms (55)

Synonym
vanadiumpentoxyde
ec 215-239-8
anhydride vanadique
nsc 215206
wanadu pieciotlenek
vanadium pentoxide, nonfused form [un2862] [poison]
vanadium, pentoxyde de
vanadium fume (v2o5)
vanadiumpentoxid
unii-bvg363oh7a
vanadio, pentossido di
vanadium dust (v2o5)
vanadium pentoxide, nonfused form
vanadium oxide (v2o5)
vanadium pentoxide
1314-62-1
CHEBI:30045 ,
divanadium pentaoxide
v2o5
vanadium(v) oxide
vanadic acid anhydride
ai3-52159
rcra waste no. p120
divanadium pentoxide
wanadu pieciotlenek [polish]
vanadium oxide v2o5
vanadiumpentoxid [german]
einecs 215-239-8
vanadic anhydride
anhydride vanadique [french]
ci 77938
vanadiumpentoxyde [dutch]
hsdb 1024
vanadin(v) oxide
rcra waste number p120
c.i. 77938
ccris 3206
vanadio, pentossido di [italian]
un2862
vanadium, pentoxyde de [french]
vanadium(v) oxide, >=98%
vanadium(v) oxide, >=99.6% trace metals basis
vanadium(v) oxide, 99.99% trace metals basis
11099-11-9
einecs 234-326-1
pentaoxodivanadium
vandia
AKOS016370678
vanadium(v) oxide, purum, >=98.0% (rt)
mfcd00011457
vanadium(v) oxide (99.99%-v)
Q409173
dioxovanadiooxy(dioxo)vanadium
vanadium(v) oxide;divanadium pentoxide;divanadium pentaoxide
BCP32217

Research Excerpts

Overview

Vanadium pentoxide (V(2)O(5) is a transition metal derived from the burning of petrochemicals that causes airway fibrosis and remodeling. It is a slightly soluble compound found in airborne particle emissions from metallurgical works and oil and coal burning.

ExcerptReferenceRelevance
"Vanadium pentoxide (V2O5) is a component of PM derived from fuel combustion as well as a source of occupational exposure in humans."( Vanadium pentoxide induces pulmonary inflammation and tumor promotion in a strain-dependent manner.
Bauer, AK; Rondini, EA; Walters, DM, 2010
)
2.52
"Vanadium pentoxide (V(2)O(5)) is a transition metal derived from the burning of petrochemicals that causes airway fibrosis and remodeling. "( Vanadium-induced HB-EGF expression in human lung fibroblasts is oxidant dependent and requires MAP kinases.
Bonner, JC; Ingram, JL; Rice, AB; Santos, J; Van Houten, B, 2003
)
1.76
"Vanadium pentoxide (V2O5) is a slightly soluble compound found in airborne particle emissions from metallurgical works and oil and coal burning. "( Carcinogenicity of inhaled vanadium pentoxide in F344/N rats and B6C3F1 mice.
Bucher, JR; Chou, BJ; Dill, JA; Hailey, JR; Haseman, JK; Miller, RA; Renne, RA; Ress, NB; Roycroft, JH, 2003
)
2.06
"Vanadium pentoxide (V(2)O(5)) is a cause of occupational asthma and bronchitis. "( Airway fibrosis in rats induced by vanadium pentoxide.
Bonner, JC; Moomaw, CR; Morgan, DL; Rice, AB, 2000
)
2.03
"Vanadium pentoxide (V(2)O(5)) is a cause of occupational asthma and chronic bronchitis, yet the molecular mechanisms through which V(2)O(5) exerts its effects on cell function are unclear. "( Mechanism of extracellular signal-regulated kinase (ERK)-1 and ERK-2 activation by vanadium pentoxide in rat pulmonary myofibroblasts.
Bonner, JC; Wang, YZ, 2000
)
1.97

Effects

ExcerptReferenceRelevance
"Vanadium pentoxide (V(2)O(5)) has attracted attention for supercapcitor applications because of its extensive multifunctional properties. "( Interconnected V2O5 nanoporous network for high-performance supercapacitors.
Muralidharan, G; Purushothaman, KK; Saravanakumar, B, 2012
)
1.82

Toxicity

ExcerptReferenceRelevance
" No adverse effects of V2O5 on pre-implantation and implantation were noted, and neither were teratogenicity and premature birth."( [A study on developmental toxicity of vanadium pentoxide in NIH mice].
Gou, X; Yang, Z; Zhang, T, 1991
)
0.55
"The toxic effects of vanadium pentoxide were investigated following chronic exposure."( Toxic effects of long-term intratracheal administration of vanadium pentoxide in rats.
Byczkowski, JZ; Kulkarni, AP; Zychlinski, L, 1991
)
0.84
" Interest for vanadium and their compounds is because its toxic effects and uses in some biomedical areas: such as antineoplastic, cholesterol and glucose level blood, diuretic, oxygen haemoglobin affinity."( [Genotoxic effects of vanadium compounds].
Altamirano-Lozano, M, 1998
)
0.3
"To study the toxic effect of vanadium-titanium-magnetite (VTM) dust on alveolar macrophage (AM) and its hazardous extent."( [An in vitro study on toxic effect of vanadium-titanium-magnetite dust on alveolar macrophage in rabbits].
Chen, Q; Guan, Y; Song, Y, 1998
)
0.3
"Toxic effect of exposure to VTM dust was lower than that to vanadium oxide and silica, but higher than that to titanium dioxide, which had slight toxic effect."( [An in vitro study on toxic effect of vanadium-titanium-magnetite dust on alveolar macrophage in rabbits].
Chen, Q; Guan, Y; Song, Y, 1998
)
0.3
" This study contributes to a better understanding of the mechanisms by which vanadium induces adverse effects in biological systems."( Sex differences in blood genotoxic and cytotoxic effects as a consequence of vanadium inhalation: micronucleus assay evaluation.
Altamirano-Lozano, M; Fortoul, TI; Rojas-Lemus, M, 2014
)
0.4

Dosage Studied

ExcerptRelevanceReference
" In both non-smokers and smokers, there was considerable variability in adjusted polymorphonuclear cell counts and a dose-response relation between these adjusted cell counts and either PM10 or respirable vanadium dust exposure could not be found."( Upper airway response in workers exposed to fuel oil ash: nasal lavage analysis.
Christiani, DC; Elreedy, S; Hauser, R; Hoppin, JA, 1995
)
0.29
" This chemical produces a clear dose-response in DNA migration in whole blood leukocytes and a significative positive effect only with the highest tested concentration in human lymphocyte cultures."( Genotoxicity of vanadium pentoxide evaluate by the single cell gel electrophoresis assay in human lymphocytes.
Altamirano-Lozano, M; Herrera, LA; Ostrosky-Wegman, P; Rojas, E; Valverde, M, 1996
)
0.64
"998) that nothing is to be gained from their use in place of the V2O5 chamber concentration in attempts to perform dose-response modeling of the tumor incidence or unit cancer risk computations."( Vanadium pentoxide: risk assessment implications of a treatment- but not dose-related tumorigenic response in B6C3F1 mice.
MacGregor, JA; Starr, TB, 2014
)
1.85
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
vanadium oxide
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (271)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (4.43)18.7374
1990's31 (11.44)18.2507
2000's72 (26.57)29.6817
2010's145 (53.51)24.3611
2020's11 (4.06)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 67.89

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index67.89 (24.57)
Research Supply Index5.62 (2.92)
Research Growth Index5.06 (4.65)
Search Engine Demand Index115.83 (26.88)
Search Engine Supply Index2.01 (0.95)

This Compound (67.89)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (1.82%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other270 (98.18%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]